News and Events > Seminars > BioBusiness Seminar Series: "Investing in BioMedical Start-up Companies and Negotiating a Venture Capital Deal"

BioBusiness Seminar Series: "Investing in BioMedical Start-up Companies and Negotiating a Venture Capital Deal"

The CU Technology Transfer Office and the Colorado Alliance for Bioengineering present the BioBusiness Seminar Series: "Investing in BioMedical Start-up Companies and Negotiating a Venture Capital Deal" with Timothy Mills, MD, Managing Director, Sanderling Investments and David Drake, Director of Business Development, University of Colorado Technology Transfer Office.

Friday, February 14, 2003
Shivers Conference Room
8th Floor, Biomedical Research Building
9th and Colorado Blvd.

10:00am: Brunch Buffet and Networking
10:30-12:00pm: Presentation and Discussion

*Seating Limited

Questions? Contact Lynn.Pae@cu.edu

Timothy Mills:
With nearly twenty years of experience in biomedical research and corporate management, Dr. Timothy Mills joined Sanderling as an Operating Partner in July 1998, and was promoted to Managing Director in 2000. At Sanderling, Dr. Mills has focused on early stage investments in Medical Devices, Biotherapeutics, and i-Health. He serves Sanderling portfolio companies as Director, Chief Executive Officer or management team member.

Prior to joining Sanderling, Dr. Mills served as the Corporate Vice President of New Business Development and Chief Scientific Officer of Target Therapeutics, a medical device company that was acquired by Boston Scientific for $1.2 billion in 1997. He also served as the Director for Prograft Medical, a Target affiliate.

Prior to joining Target in 1994, Dr. Mills served as Director of Business Development and Advanced Research & Development in the Interventional Cardiology Division of Baxter Healthcare. Dr. Mills' academic appointments include service as the Director of the Artificial Heart Program at the University of California, Irvine Medical Center and membership in the University of California, San Francisco Radiology Department.

Dr. Mills received his Ph.D. in Bioengineering from the University of California, Berkeley & San Francisco School of Medicine, his M.S. in Electrical Engineering & Computer Science from the University of California, Berkeley, and his B.S. in Electrical Engineering from the University of Colorado, Boulder.

David Drake:
Dave's background is in early-stage venture capital investing and management of seed/early-stage start-ups. He has served in two venture capital funds, Colorado Venture Management and Cornerstone Ventures. He is currently a director of Information Retrieval Methods, Inc., a data optimization company for consumer goods manufacturers. Dave also volunteers as an advisor to clients at Ctek (formerly the Colorado Technology Incubator) and he serves as an adjunct professor for the business plan preparation course at CU's Leeds School of Business.

Dave's prior experience includes numerous roles in all aspects of senior management at start-ups ranging from 5 to 50 employees. He served as chairman and CEO of HeurisTec Corporation, a software company employing technology originally developed at CU. Dave specializes in technology company creation, mergers, and acquisitions. Earlier, he held marketing and consulting positions at Procter & Gamble and McKinsey & Company.

Dave has a BA in history and Japanese from Colgate University and an MBA from the Harvard School of Business.